The Effect of IL-10 on M2-Activated Human Microglia (S12.006)
DOI:
10.1212/wnl.84.14_supplement.s12.006
Publication Date:
2023-12-06T23:42:28Z
AUTHORS (6)
ABSTRACT
OBJECTIVE: To investigate the effect of IL-10 on phenotypic characteristics M2 polarized human microglia. BACKGROUND: Myeloid cells acquire distinct immunologic phenotypes dependent their state 'polarization': either 'M1' (pro-inflammatory) or 'M2' (anti-inflammatory). cells, generated using mCSF/IL-4/IL13, produce increased quantities anti-inflammatory cytokines and display phagocytic activity expression scavenger receptors. Previous in vitro studies show that mCSF/IL-4/IL13 treated microglia express more limited functional properties than blood-derived macrophages. Rodent-based have defined subsets (M2a, M2b M2c) within overall population thus far not been investigated system. Human M2c macrophages induced by treatment with combination (M2a protocol) enhancement aforementioned M2-like properties. DESIGN/METHODS: were cultured from both fetal adult brain tissue; these exposure to ± (50ng/ml). Phenotypic markers (cell surface intra-cellular) assessed way multi-colour flow cytometery qPCR. In situ myeloid was demonstrated immunohistochemical staining post-mortem CNS tissue. RESULTS: We able demonstrate higher specific markers, CD163 HMOX-1, presence compared M2a conditions alone; CD206 CD209 comparably expressed. Analysis a case Schistosoma mekongi parasitic infection confirmed is selectively expressed its elevated under pathologic condition promotes Th2 responses. CONCLUSIONS: Our findings induces vitro, pathological associated levels are also likely induce such situ.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....